logo
Select company
Select metric
$ 7.81MWorking Capital
VS
Market
33
Sector
26
Industry
19
History
75
$ 5.49Close
$ 1.36 - $ 5.68 52-Week Range
Ticker Information

Ticker

NEPH

Company Name

NEPHROS INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

NEPHROS INC - Working Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NEPH - Working Capital Historical data
DateCurrent AssetsCurrent LiabilitiesWorking Capital
6/30/2025$ 9.58M$ 1.77M$ 7.81M
3/31/2025$ 8.99M$ 1.52M$ 7.47M
12/31/2024$ 8.3M$ 1.56M$ 6.74M
9/30/2024$ 7.36M$ 1.06M$ 6.3M
6/30/2024$ 7.93M$ 1.95M$ 5.97M
3/31/2024$ 8.13M$ 1.93M$ 6.2M
12/31/2023$ 8.4M$ 2.11M$ 6.29M
9/30/2023$ 8.51M$ 1.83M$ 6.68M
6/30/2023$ 7.91M$ 1.2M$ 6.72M
3/31/2023$ 8.32M$ 1.42M$ 6.91M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NEPHROS INC's latest trailing twelve months (TTM) Working Capital stands at $ 9.38M.
  • Over the past 5 years, NEPHROS INC's average Working Capital has been $ 8.63M.
  • The median Working Capital for NEPHROS INC during this period was $ 7.52M
  • NEPHROS INC reached its highest Working Capital over the past 5 years at $ 13.83M.
  • The lowest Working Capital recorded by NEPHROS INC in the same timeframe $ 5.97M

NEPHROS INC's Working Capital vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Working Capital Benchmarks
CompanyWorking Capital
POCI : PRECISION OPTICS CORPORATION INC $ 3.91MNXGL : NEXGEL INC $ 1.77MEKSO : EKSO BIONICS HOLDINGS INC $ 9.26MVVOS : VIVOS THERAPEUTICS INC $ 304KXLO : XILIO THERAPEUTICS INC $ 70.46MFEMY : FEMASYS INC $ -1.21MMLSS : MILESTONE SCIENTIFIC INC $ 3.86MGBIO : GENERATION BIO CO $ 126.13MPRPO : PRECIPIO INC $ -300KBNGO : BIONANO GENOMICS INC $ 18.48M

Definition of Working Capital

[Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for NEPHROS INC is calculated as follows: AssetsC [ $ 11.76M ] - LiabilitesC [ $ 2.38M ]
(=) Working Capital [ $ 9.38M ]

NEPH - Working Capital, Last 5 years

$ 5.97M

Minimum

Jun 30, 2024

$ 13.83M

Maximum

Dec 31, 2020

$ 8.63M

Average

$ 7.52M

Median

Working Capital Benchmark Analysis

The chart above depicts the distribution of Working Capital for companies in the Total Stock Market. The average Working Capital of the companies is $ 96.6M with a standard deviation of $ 173.49M.
The following table provides additional summary stats:
Working Capital in the Market:
filtered constituents2.78K
min$ -457.39M
max$ 607.04M
average$ 96.6M
median$ 32.21M
std$ 173.49M